A Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer
[Protocol 11-039] |
Abou-Alfa, Ghassan |
|
A Phase IB Study of Vismodegib in Patients with Liver Cancer with Varying Degrees of Kidney and Liver Function
[Protocol 12-031] |
Abou-Alfa, Ghassan |
|
A Phase I Study of GC33 plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
[Protocol 10-021] |
Abou-Alfa, Ghassan |
|
A Phase II Study of GC33 in Patients with Advanced Hepatocellular Carcinoma
[Protocol 12-145] |
Abou-Alfa, Ghassan |
|
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
[Protocol 11-211] |
Abou-Alfa, Ghassan |
|
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259] |
Abou-Alfa, Ghassan |
|
A Phase III Study of ADI-PEG20/Supportive Care or Placebo/Supportive Care in Patients with Advanced Liver Cancer
[Protocol 11-081] |
Abou-Alfa, Ghassan |
|
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079] |
Ahles, Tim |
|
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
[Protocol 07-130] |
Ahles, Tim |
- Breast Cancer
- Survivorship
|
A Study of SOM230 to Reduce the Risk of Fistulas, Leaks, and Abscesses After Pancreatic Surgery
[Protocol 09-039] |
Allen, Peter |
- Hepatobiliary
- Survivorship
- Upper Gastrointestinal
|
A Phase III Study of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy in Patients with Cutaneous Melanomas that Have Metastasized to the Sentinel Node
[Protocol 09-112] |
Ariyan, Charlotte |
|
A Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101] |
Ariyan, Charlotte |
|
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071] |
Bajorin, Dean |
|
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer
[Protocol 10-106] |
Bajorin, Dean |
|
A Phase II Study of Gemcitabine and Pazopanib in Previously Untreated Patients with Advanced Urothelial Cancers Who Cannot Receive Cisplatin
[Protocol 11-191] |
Bajorin, Dean |
- Bladder Cancer
- Kidney Cancer
|
A Phase II Study of DN24-02 as Adjuvant Therapy in Patients with High-Risk HER2-positive Urothelial Cancers
[Protocol 11-163] |
Bajorin, Dean |
|
A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025] |
Bajorin, Dean |
- Bladder Cancer
- Hereditary Cancer & Genetics
|
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060] |
Bajorin, Dean |
|
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
[Protocol 08-087] |
Barker, Juliet |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
- Hematology
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
|
Transplantation of Unrelated Donor Double-Unit Cord Blood with T-Cell-Depleted Stem Cells for Patients with High-Risk Hematologic Cancers
[Protocol 12-153] |
Barker, Juliet |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
- Hematology
- Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
|
